Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.

Keitel WA, Voronca DC, Atmar RL, Paust S, Hill H, Wolff MC, Bellamy AR; VTEU H5N1 Vaccine Working Group.

Vaccine. 2019 Sep 3;37(37):5535-5543. doi: 10.1016/j.vaccine.2019.04.066. Epub 2019 May 31. Review.

PMID:
31160101
2.

Unexpected High Second-Order Nonlinear Optical Activity of Metal Complexes with Three-Branched Hexadentate 2,2'-Bipyridine Ligands.

Wolff MC, van Steerteghem N, Clays K, Heck J.

Chemistry. 2018 Oct 9;24(56):14901-14905. doi: 10.1002/chem.201801189. Epub 2018 Sep 11.

PMID:
29989225
3.

Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.

Halasa NB, Gerber MA, Berry AA, Anderson EL, Winokur P, Keyserling H, Eckard AR, Hill H, Wolff MC, McNeal MM, Edwards KM, Bernstein DI.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):214-24. doi: 10.1093/jpids/piu061. Epub 2014 Jun 27.

4.

2,2'-Bipyridine-based dendritic structured compounds for second harmonic generation.

Büchert M, Steenbock T, Lukaschek C, Wolff MC, Herrmann C, Heck J.

Chemistry. 2014 Oct 27;20(44):14351-61. doi: 10.1002/chem.201404001. Epub 2014 Sep 22.

PMID:
25251846
5.

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, Kotloff KL, Rouphael N, Noah DL, Hill H, Wolff MC.

J Infect Dis. 2012 Sep 15;206(6):811-20. doi: 10.1093/infdis/jis427. Epub 2012 Jul 10.

6.

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, Pileri P, Ray R, Di Bisceglie AM, Rinella P, Hill H, Wolff MC, Schultze V, Han JH, Scharschmidt B, Belshe RB.

Vaccine. 2010 Aug 31;28(38):6367-73. doi: 10.1016/j.vaccine.2010.06.084. Epub 2010 Jul 7.

7.

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

Noah DL, Hill H, Hines D, White EL, Wolff MC.

Clin Vaccine Immunol. 2009 Apr;16(4):558-66. doi: 10.1128/CVI.00368-08. Epub 2009 Feb 18.

8.

In utero antiepileptic drug exposure: fetal death and malformations.

Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC; NEAD Study Group.

Neurology. 2006 Aug 8;67(3):407-12.

9.

Acute exposure to a novel object during consolidation enhances cognition.

Degroot A, Wolff MC, Nomikos GG.

Neuroreport. 2005 Jan 19;16(1):63-7.

PMID:
15618892
10.

SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task.

Wolff MC, Leander JD.

Eur J Pharmacol. 2003 Sep 23;477(3):213-7.

PMID:
14522359
11.

Comparison of the effects of antipsychotics on a delayed radial maze task in the rat.

Wolff MC, Leander JD.

Psychopharmacology (Berl). 2003 Aug;168(4):410-6. Epub 2003 Apr 23.

PMID:
12709778
12.
13.

Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.

Isa MB, Martínez L, Giordano M, Passeggi C, de Wolff MC, Nates S.

Clin Diagn Lab Immunol. 2002 May;9(3):693-7.

14.

[Resurgence of measles in the province of Cordoba, Argentina, in 2000].

Isa MB, Martinez LC, Giordano MO, Ferreyra LJ, Gonzalez M, Glatstein N, Passeggi C, De Wolff MC, Nates SV.

Rev Argent Microbiol. 2001 Oct-Dec;33(4):229-34. Spanish.

PMID:
11833255
15.

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, Cho I, Marcy SM, Iacuzio D, Belshe RB.

Pediatrics. 2001 Aug;108(2):E24.

PMID:
11483834
16.

Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

Isa MB, Martínez L, Giordano M, Zapata M, Passeggi C, De Wolff MC, Nates S.

J Clin Microbiol. 2001 Jan;39(1):170-4.

17.

A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon.

Wolff MC, Leander JD.

Behav Pharmacol. 2000 Aug;11(5):355-64.

PMID:
11103887
18.

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

Rasmussen K, Calligaro DO, Czachura JF, Dreshfield-Ahmad LJ, Evans DC, Hemrick-Luecke SK, Kallman MJ, Kendrick WT, Leander JD, Nelson DL, Overshiner CD, Wainscott DB, Wolff MC, Wong DT, Branchek TA, Zgombick JM, Xu YC.

J Pharmacol Exp Ther. 2000 Aug;294(2):688-700.

PMID:
10900249
19.

Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination.

Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, Munoz FM, Wolff MC.

Pediatr Infect Dis J. 2000 May;19(5):417-23.

PMID:
10819337
20.

The discriminative stimulus properties of LY233708, a selective serotonin reuptake inhibitor, in the pigeon.

Wolff MC, Leander JD.

Psychopharmacology (Berl). 1999 Oct;146(3):275-9.

PMID:
10541727
21.

[Measles outbreak in the province of Córdoba, Argentina, in 1998].

Isa MB, González M, Martínez LC, Giordano MO, López De Neira MJ, Passeggi C, De Wolff MC, Nates SV.

Rev Argent Microbiol. 1999 Apr-Jun;31(2):90-5. Spanish.

PMID:
10425666
22.

A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children.

Wolff MC, Moulton LH, Newcomer W, Reid R, Santosham M.

Am J Trop Med Hyg. 1999 Feb;60(2):263-6.

PMID:
10072148
23.
24.

Effects of a 5-HT1A receptor agonist on acute and delayed cyclophosphamide-induced vomiting.

Wolff MC, Leander JD.

Eur J Pharmacol. 1997 Dec 11;340(2-3):217-20.

PMID:
9537818
25.

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE.

J Infect Dis. 1998 Feb;177(2):310-9.

PMID:
9466516
26.

Differentiation of 5-HT1A receptor ligands by drug discrimination.

Wolff MC, Leander JD.

Eur J Pharmacol. 1997 Aug 27;333(2-3):113-22.

PMID:
9314023
27.

Comparison of the antiemetic effects of a 5-HT1A agonist, LY228729, and 5-HT3 antagonists in the pigeon.

Wolff MC, Leander JD.

Pharmacol Biochem Behav. 1995 Nov;52(3):571-5.

PMID:
8545476
28.

Case-cohort analysis of case-coverage studies of vaccine effectiveness.

Moulton LH, Wolff MC, Brenneman G, Santosham M.

Am J Epidemiol. 1995 Nov 1;142(9):1000-6.

PMID:
7572966
29.

Decision making during a phase III randomized controlled trial.

Berry DA, Wolff MC, Sack D.

Control Clin Trials. 1994 Oct;15(5):360-78.

PMID:
8001357
30.

Antiemetic effects of 5-HT1A agonists in the pigeon.

Wolff MC, Leander JD.

Pharmacol Biochem Behav. 1994 Oct;49(2):385-91.

PMID:
7824554
31.

Passive immunization for infection with Haemophilus influenzae type b.

Santosham M, Reid R, Letson GW, Wolff MC, Siber G.

Pediatrics. 1990 Apr;85(4 Pt 2):662-6. Review.

PMID:
2179857
32.

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.

Santosham M, Reid R, Ambrosino DM, Wolff MC, Almeido-Hill J, Priehs C, Aspery KM, Garrett S, Croll L, Foster S, et al.

N Engl J Med. 1987 Oct 8;317(15):923-9.

PMID:
2442610
33.

Nutritional status of children in the health district of Cusco, Peru.

Wolff MC, Perez L, Gibson JG, Lopez LS, Peniston B, Wolff MM.

Am J Clin Nutr. 1985 Sep;42(3):531-41.

PMID:
4036851
34.

Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant.

Dubin NH, Wolff MC, Thomas CL, DiBlasi MC.

Toxicol Appl Pharmacol. 1985 May;78(3):458-63.

PMID:
4049394

Supplemental Content

Loading ...
Support Center